Robert Nshimiyimana | Molecular Biology | Best Researcher Award

Posted on 28/03/202528/03/2025 by ScienceFather

Robert Nshimiyimana | Molecular Biology | Best Researcher Award

Dr Robert Nshimiyimana, Harvard Medical School, United States

Dr. Robert Nshimiyimana is a postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School, specializing in organic chemistry, biochemistry, and molecular biology. His research explores the identification of bioactive chemical signals, pathways, and cellular targets that enhance the innate resolution of inflammation. His contributions to inflammation resolution research have provided critical insights into therapeutic strategies for diseases driven by chronic inflammation. With expertise in mass spectrometry, nuclear magnetic resonance spectroscopy, and lipidomics, he plays a pivotal role in deciphering pro-resolving mediators in human biology. His work has resulted in multiple high-impact publications and recognition at prestigious international conferences. Passionate about mentoring and scientific outreach, Dr. Nshimiyimana is committed to advancing biomedical research and fostering collaborations to translate laboratory discoveries into clinical applications. His dedication to excellence and groundbreaking research make him a strong candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Robert Nshimiyimana holds a Ph.D. in Organic Chemistry from the University of Southern California (USC), where he conducted cutting-edge research in bioorganic synthesis and lipid mediators of inflammation. His doctoral work focused on developing synthetic pathways for bioactive molecules that regulate the inflammatory response. Prior to that, he earned a B.A. in Biochemistry and Molecular Biology from Hendrix College, where he gained foundational expertise in chemical biology and enzymology. As part of his academic journey, Dr. Nshimiyimana participated in an International Student Exchange Program (ISEP) at Ulster University, Northern Ireland, broadening his scientific perspective and fostering global collaborations. His multidisciplinary education in chemistry, molecular biology, and biochemistry has provided him with a unique skill set to tackle complex biomedical challenges. His academic excellence and research contributions have established him as a rising leader in inflammation resolution and lipidomics research.

Experience

Dr. Robert Nshimiyimana has held multiple prestigious research positions, including his current role as a postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School. Here, he investigates pro-resolving lipid mediators and their role in inflammation resolution. 📚 During his Ph.D. at USC, he served as a graduate research associate, focusing on the total synthesis of bioactive molecules and their impact on cellular signaling pathways. His research contributed to developing novel therapeutics targeting chronic inflammatory diseases. 👨‍🏫 Additionally, he has served as an instructor and teaching assistant for organic chemistry and biochemistry, mentoring students in advanced analytical techniques such as NMR, mass spectrometry, and chromatography. 💡 His expertise in chemical biology, lipidomics, and bioorganic chemistry has positioned him as a leading scientist in the study of inflammation and disease mechanisms, making him a prime candidate for the Best Researcher Award.

Awards and Honors

Dr. Robert Nshimiyimana has been recognized with numerous prestigious awards, highlighting his impactful contributions to biomedical research. ✨ He received the Best Oral Presentation Award at the 16th World Congress on Inflammation, showcasing his expertise in pro-resolving lipid mediators. ✈️ He was also awarded the Eicosanoid Research Foundation (ERF) Travel Award, enabling him to present groundbreaking research on lipid mediators and inflammation resolution at leading international conferences. 🔬 Beyond research, he serves as a peer reviewer for renowned journals, including Current Organic Chemistry, Current Materials Science, and Tetrahedron Letters, contributing to scientific advancement. His dedication to biomedical innovation, mentorship, and scholarly excellence has earned him global recognition. His commitment to advancing inflammation research through novel therapeutic strategies cements his reputation as a top-tier researcher and a deserving recipient of the Best Researcher Award.

Research Focus

Dr. Robert Nshimiyimana’s research focuses on the identification of bioactive chemical signals, pathways, and cellular targets responsible for stimulating the innate resolution of inflammation. His work integrates organic chemistry, biochemistry, and molecular biology to investigate how lipid mediators regulate immune responses and promote tissue healing. 🔍 Using advanced analytical techniques like mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy, he studies the biosynthesis and function of pro-resolving mediators such as resolvins, maresins, and lipoxins. His research aims to develop therapeutic interventions targeting inflammatory diseases, including arthritis, pneumonia, and lung injury. 🌎 His innovative studies have profound clinical implications, potentially leading to new treatments for chronic inflammatory disorders. With a track record of high-impact publications and groundbreaking discoveries, Dr. Nshimiyimana is at the forefront of inflammation resolution research, making him an exceptional candidate for the Best Researcher Award.

Publication Top Notes

A new E-series resolvin: RvE4 stereochemistry and function in efferocytosis of inflammation-resolution

E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for …

Elovanoids counteract oligomeric β-amyloid-induced gene expression and protect photoreceptors

Human leukocytes selectively convert 4S,5S-epoxy-resolvin to resolvin D3, resolvin D4, and a cys-resolvin isomer

Stereospecific metabolism of R-and S-warfarin by human hepatic cytosolic reductases

Infectious neutrophil deployment is regulated by resolvin D4

ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea

Elucidating the structure and functions of Resolvin D6 isomers on nerve regeneration with a distinctive trigeminal transcriptome

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Posted on 15/03/202515/03/2025 by ScienceFather

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Posted on 13/03/202513/03/2025 by ScienceFather

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Wei Liu Hunan, University of Chinese Medicine, China

Prof. Dr. Wei Liu is a distinguished scholar in Artificial Intelligence 🤖, Medical Informatics 🏥, and Intelligent Software Engineering 💻, serving as Deputy Dean at Hunan University of Chinese Medicine. With a Ph.D. in Engineering 🎓, he has made groundbreaking contributions through 100+ research papers 📄 (30+ indexed in SCI/EI), 2 monographs 📚, and 9 textbooks 📖. His 30+ software copyrights 💡 and leadership in 20+ major projects 🚀, including collaborations with Huawei and national research foundations, solidify his expertise. As a Young Backbone Teacher of Hunan Province, he also excels in mentoring, guiding students to 300+ awards 🏅, including 10+ national gold prizes 🏆. His teaching innovation has earned him national and provincial-level honors, while his contributions to Traditional Chinese Medicine (TCM) Informatics 🌿 further highlight his multidisciplinary excellence. Recognized as a National Certified System Architect 🏗️, SCI journal reviewer 🧐, and a member of CCF, ACM, and CAIS, Prof. Liu is a true leader in his field.

Publication Profile

Scopus

Education

Prof. Dr. Wei Liu holds a Ph.D. in Engineering (Computer Application Technology) 🖥️ from a prestigious institution, where he specialized in Artificial Intelligence 🤖 and Medical Informatics 🏥. His doctoral research focused on intelligent software systems, integrating machine learning 📊 with healthcare applications 🏩. Prior to his Ph.D., he completed his Master’s degree 🎓 in Computer Science, gaining deep expertise in data-driven decision-making 💾 and intelligent algorithms 🔍. His academic journey also includes undergraduate studies in Software Engineering 💡, where he built a strong foundation in computational intelligence 🧠, biomedical computing 🏥, and software development 💻. With an interdisciplinary education spanning engineering, computer science, and informatics, Prof. Liu combines technical depth with practical innovation, making his academic background perfectly suited for pioneering AI-driven healthcare solutions 🚑. His commitment to education 📚 continues as he mentors students and professionals in next-generation AI research and applications 🤖📊.

Experience

Prof. Dr. Wei Liu serves as the Deputy Dean of the School of Informatics 🏛️ at Hunan University of Chinese Medicine, leading research in Artificial Intelligence 🤖, Medical Informatics 🏥, and Software Engineering 💻. As a Professor and Senior Engineer 👨‍🔬, he supervises Master’s students 🎓, guiding them in cutting-edge AI research 🚀. With a rich teaching career 📚, he has developed three top-level provincial courses 🎖️ and ranked 1st in the Hunan Provincial Teaching Competition 🏆. His industry collaborations with Huawei and leadership in 20+ national projects 🏗️ highlight his practical impact 🌍. He actively contributes as a Vice President of the Hunan Association for TCM Informatics 🌿 and serves on multiple national AI and computing committees 🤝. His work as an SCI journal reviewer 🧐 and National Certified System Architect 🏗️ ensures that his research, teaching, and innovation continue to shape the future of AI-driven medical solutions 🔬.

Awards & Honors

Prof. Dr. Wei Liu is a distinguished researcher and educator 🌟, renowned for his contributions to AI, medical informatics, and teaching innovation 📚. His accolades include the National Teaching Innovation Competition Second Prize 🏆 (2024), 1st Place in the Hunan Provincial Teaching Competition 🎖️, and the National TCM Informatics Teaching Gold Prize 🏅. He has been honored as the “Most Knowledgeable Young Teacher” in Hunan Province 🏆 and recognized as a Young Backbone Teacher 👨‍🏫. A recipient of the Huawei Industry-Academia Collaboration Excellence Award 🏅, he also serves as an Executive Member of National AI Committees 🤖. His mentorship has led students to win 300+ awards 🏆, including over 10 national gold prizes 🥇. As a pioneer in AI-driven medical technologies 🌍, his impact extends across academia and industry 🚀.

Research Focus

Prof. Dr. Wei Liu’s research spans Artificial Intelligence 🤖, Medical Informatics 🏥, and Intelligent Software Engineering 💻, focusing on AI-driven healthcare solutions 📊, big data analysis 🏩, and intelligent diagnosis 🏥. His expertise includes AI-based disease prediction, NLP for medical data 📜, deep learning for medical imaging 🧠📸, and IoT-driven smart healthcare 🚑. Integrating AI with Traditional Chinese Medicine 🌿🤖, he pioneers innovative patient care solutions. With 30+ software copyrights 💡, 100+ high-impact publications 📄, and national-level projects—including Huawei collaborations 🚀—his work enhances precision medicine, diagnostics, and medical software applications 🌍, revolutionizing healthcare technology.

Publication Top Notes

Recognition of Hand-Drawn Hydrocarbon Structure Formulas Using Anchor-Free Detector

Classification of cold and hot medicinal properties of Chinese herbal medicines based on graph convolutional network

ChemReco: automated recognition of hand-drawn carbon–hydrogen–oxygen structures using deep learning

SQCS: A sustainable quality control system for spatial crowdsourcing via three-party evolutionary game: Theory and practice

Truth based three-tier Combinatorial Multi-Armed Bandit ecosystems for mobile crowdsensing

YoDe-Segmentation: automated noise-free retrieval of molecular structures from scientific publications

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Posted on 07/03/202507/03/2025 by ScienceFather

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Dr VIVEKANAND ASHOK, Azeezia Health City, India

Dr. Vivekanand Ashok is a dedicated otorhinolaryngologist with a passion for research and surgical excellence. His extensive work spans cochlear implants, otologic surgeries, and head and neck disorders. With numerous high-impact publications in esteemed journals, his research has significantly contributed to advancements in ENT care. His clinical expertise in endoscopic sinus surgery, thyroid disorders, and voice disorders, combined with his academic contributions, makes him a deserving candidate for the Best Researcher Award. His continuous pursuit of innovation in ENT treatments, active participation in conferences, and commitment to medical education further solidify his reputation as an outstanding researcher. 🏅📚🔬

Publication Profile

Orcid

Education

Dr. Vivekanand Ashok 🎓 pursued his MBBS from Azezia Institute of Medical Sciences, Kerala (2014) 🏥📖, followed by an M.S in ENT from Bangalore Medical College and Research Institute, Karnataka (2020) 🎓🩺. He further obtained a DNB (ENT) in 2021 🏅📚 and completed a Fellowship in Cochlear Implant Surgery at GMERS Gandhinagar in 2023 🎧🔬. With a strong foundation in otorhinolaryngology, he specializes in ENT surgeries and cochlear implants, demonstrating his dedication to patient care. His rigorous training at top institutions has equipped him with expertise in handling complex ENT cases, establishing him as a leader in the field. 📘💉🔍

Experience

Dr. Vivekanand Ashok is a distinguished ENT specialist with extensive experience in medical education, clinical practice, and research. He served as a Senior Resident at Karnataka Institute of Medical Sciences (2020-2021) 🏨👨‍⚕️ and Malabar Cancer Centre, Kerala (2021-2022) 🎗️🏥, honing his expertise in otolaryngology. Transitioning into academia, he worked as an Assistant Professor at Karuna Medical College, Kerala (2022-2024) 🎓📖, shaping future medical professionals. Currently, he excels as a Senior Consultant at Co-operative Hospital, Kattappana (2024-2025) 🏨🩺 and Azeezia Health City, Palakkad (2025-Present) ⚕️🔬. His dedication to patient care and surgical excellence makes him a respected figure in the field. 🏆👨‍⚕️

Awards & Honors

Dr. Vivekanand Ashok’s dedication to academic excellence and research has earned him prestigious accolades in the field of ENT. He secured 3rd position in the South Zone ENT Quiz (2018) 🥉🧠, demonstrating his deep knowledge and expertise. In 2019, he was a Zonal Round Participant in the South Zone Young Scholar Award 🎖️📖, further highlighting his commitment to continuous learning and professional growth. These achievements reflect his passion for advancing medical knowledge and contributing to the field of otolaryngology. Through his dedication to research and education, Dr. Ashok continues to make a significant impact in the medical community. 🏆🔬

Research Focus

Dr. Ashok specializes in otorhinolaryngology, cochlear implants, head and neck surgery, and otologic diseases. His research focuses on laryngopharyngeal reflux, rhino-orbital mucormycosis, thyroid carcinomas, and nasal hemangiomas. His work has contributed to improving diagnostic techniques and treatment approaches in ENT disorders. With a passion for innovation, he continues to explore advancements in hearing restoration, sinus surgery, and minimally invasive ENT procedures. 🎧👂📊

Publication Top Notes

Unmasking the Fungal Menace: A Case Report of Chronic Granulomatous Invasive Fungal Sinusitis of Maxilla

Clinical features, diagnosis, and treatment outcome of Rhino-orbito-cerebral mucormycosis: A 2-year experience at a tertiary care center

Extrapulmonary head and neck tuberculosis: 3 year experience at a tertiary care centre

Nasal haemangioma as a cause of epistaxsis: a case report

Laryngopharyngeal reflex – Diagnosis and management at atertiary care centre

Nasal cavity extramedullary plasmacytoma: literature review and clinical experience

Lei Tong | Medicine and Health Sciences | Best Researcher Award

Posted on 03/03/202503/03/2025 by ScienceFather

Lei Tong | Medicine and Health Sciences | Best Researcher Award

Dr Lei Tong, China Academy of Chinese Medical Sciences, China

Dr. Aayushi 🧪🎓 is a highly accomplished researcher in Chemical Sciences, securing an All India Rank of 02 in CSIR NET (Dec 2023) 🏆. She qualified IIT JAM (2017) and received prestigious scholarships, including the CBSE CSSS (2014-2019) and Thapar Institute Merit Scholarship (2018) 🎖️. Honored with the Young Achiever Award (2021) 🌟, she excelled in research, winning Best Oral Presentation at EMSD-2022 🗣️ and Best Poster Award at CEEMS Doctorate Scholar’s Day-2024 🖼️. Her work on carbon quantum dots for metal ion detection highlights her expertise in materials science and sensors 🔬⚛️.

Publication Profile

Orcid

Education

Dr. Lei Tong 🏮🔬 is a dedicated research assistant at the Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences (since August 2023). With a strong academic foundation, Dr. Tong earned a Ph.D. (2018-2023) and a Bachelor’s degree (2014-2018) from the University of Science and Technology Beijing 🎓. His research integrates traditional Chinese medicine with modern scientific methodologies, contributing to innovative medical advancements. Passionate about bridging ancient wisdom with contemporary research, Dr. Tong continues to explore fundamental theories in Chinese medicine to enhance healthcare solutions. 🌿📚🔎

Research

Dr. Lei Tong focuses on integrating stem cells, organoids, microfluidic chips, and single-cell omics 🧬🔬 to develop a multi-organoid chip model for understanding disease and syndrome interactions in Traditional Chinese Medicine (TCM) 🌿. This innovative approach deciphers the spatio-temporal evolution of TCM syndromes and their biological basis. Additionally, Dr. Tong utilizes chromatogram-mass spectrometry, bioinformatics, and metabolomics 🧪📊 to identify active components in classic prescriptions, tracing their path to the brain 🧠. His research unveils the multi-component, multi-cell, multi-target neuroprotective mechanisms of TCM, offering new insights into holistic healing and modern medical applications. 🌍💊

Project

Dr. Lei Tong is actively engaged in pioneering research in Traditional Chinese Medicine (TCM) 🌿🔬. He leads multiple prestigious projects, including the Youth Project of Beijing Natural Science Foundation (2024-2026) 🏅, and the Science and Technology Innovation Project of the China Academy of Chinese Medical Sciences (2023-2025) 💡. Additionally, he is part of the Special Project for Training Outstanding Young Scientific and Technological Talents (2023-2026) 🎓 and a key researcher at the Research Institute of Basic Theories of TCM (2024-2027) 📚. His work contributes to advancing innovative technologies and methodologies in TCM for future medical breakthroughs 🌏✨.

Research Focus

Dr. Lei Tong’s research primarily focuses on neurodegenerative diseases 🧠🦠, particularly Parkinson’s disease (PD) 🏥🧬. His work explores novel therapeutic strategies, including herbal medicine 🌿, stem cell therapy 🧑‍🔬🧫, and nanotechnology-based drug delivery 💊🔬. He investigates neuronal synaptic plasticity 🔗, oligodendrocyte apoptosis ⚡, and inflammation control 🔥 to mitigate PD progression. Additionally, his studies extend to brain organoids 🏗️🧠 for drug discovery and protein aggregation targeting 🏹 in neurodegeneration. His interdisciplinary approach also includes fluorescent sensing 🟣🔍 for cellular applications. Dr. Tong’s research bridges neuroscience, regenerative medicine, and nanotechnology for innovative neuroprotection strategies. 🚀

Publication Top Notes

Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases.

Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson’s Disease.

Targeting small heat shock proteins to degrade aggregates as a potential strategy in neurodegenerative diseases.

Human gingival mesenchymal stem cells improve movement disorders and tyrosine hydroxylase neuronal damage in Parkinson disease rats.

A porphyrin-triazatruxene dyad for ratiometric two-photon fluorescent sensing of intracellular viscosity.

Hydrogel supplemented with human platelet lysate enhances multi-lineage differentiation of mesenchymal stem cells.

Chitosan Hydrogel Supplemented with Metformin Promotes Neuron-like Cell Differentiation of Gingival Mesenchymal Stem Cells.

Comparative proteomics analysis of human stem cells from dental gingival and periodontal ligament.

Kangyu Wang | Biology and Life Sciences | Best Researcher Award

Posted on 26/02/202503/03/2025 by ScienceFather

Kangyu Wang | Biology and Life Sciences | Best Researcher Award

Kangyu Wang,Jilin Agricultural University,China

Assoc. Prof. Dr. Kangyu Wang is a distinguished researcher in biotechnology, synthetic biology, and bioinformatics at Jilin Agricultural University, China. He earned his Ph.D. in Crop Science (2015), focusing on functional gene expression in Jilin Ginseng (Panax ginseng). With over a decade of academic experience, he has contributed significantly to plant molecular biology 🌱, particularly in ginsenoside biosynthesis. He serves on the Youth Editorial Board of Chinese Herbal Medicines and Journal of Jilin Agricultural University. Dr. Wang has secured multiple research grants and has authored impactful publications 📚 in plant science journals.

publication profile

scopus

Education

Weighted Gene Co-Expression Network Analysis (WGCNA) was used to identify key genes involved in ginsenoside biosynthesis in ginseng adventitious roots under methyl jasmonate (MeJA) treatment 🌱🧬. This study by Kangyu Wang explored gene expression patterns and co-expression modules to uncover potential regulatory genes. The findings revealed significant gene clusters linked to ginsenoside production, offering insights into metabolic pathways and secondary metabolite regulation 🔬🧪. The results provide a foundation for enhancing ginsenoside yield through genetic and biotechnological approaches, contributing to the pharmaceutical and agricultural industries 💊🌿. This research advances our understanding of molecular mechanisms in ginseng metabolism.

Employment History

Dr. Kangyu Wang has been an Associate Professor since 2021, following five years as a Lecturer. His expertise spans biotechnology 🧬, synthetic biology 🏗️, and bioinformatics 💻, reflecting his dedication to research-driven education. His rapid progression from Lecturer to Associate Professor within just five years highlights his strong research contributions 📚 and academic excellence 🎓. Dr. Wang plays a crucial role in advancing scientific knowledge, mentoring students, and fostering innovation in his field. His commitment to cutting-edge research and teaching continues to shape the future of biotechnology and bioinformatics, making a significant impact on academia and industry alike.

Research Grant

Assoc. Prof. Dr. Kangyu Wang has successfully secured multiple research grants from prestigious funding bodies, including the Department of Science and Technology of Jilin Province and the Department of Education of Jilin Province. 🏅 His ability to attract research funding highlights his strong research capabilities, innovation, and leadership in executing significant scientific projects. 🔬✨ These grants not only reflect his expertise in advancing scientific knowledge but also his dedication to pioneering research that contributes to technological and academic progress. 📚💡 Dr. Wang’s achievements showcase his commitment to excellence in research and his impact on the scientific community.

Research Focus

Assoc. Prof. Dr. Kangyu Wang’s research primarily focuses on plant biology, with a special emphasis on the molecular mechanisms governing plant growth and stress responses. His recent studies delve into the physiological and biochemical processes in plants, aiming to enhance crop resilience and productivity. Dr. Wang has contributed significantly to understanding plant responses to various stressors, including hormonal influences and environmental challenges. His work not only advances fundamental plant science but also offers practical applications in agriculture, particularly in improving crop yields and stress tolerance. Through his leadership in research projects, Dr. Wang continues to impact the scientific community and agricultural practices.

Academic Service

Assoc. Prof. Dr. Kangyu Wang is a distinguished researcher known for his significant contributions across multiple disciplines, including plant biology 🌿, civil engineering 🏗️, and philosophy 🧠. His interdisciplinary expertise has led to groundbreaking research that has been published in high-impact journals 📚, showcasing his ability to bridge diverse fields. With a keen interest in scientific exploration and innovation, Dr. Wang continues to push the boundaries of knowledge, making a lasting impact on both academia and practical applications. His work reflects a unique blend of scientific rigor and philosophical depth, solidifying his reputation as a leading scholar.

Publication Top Notes

1️⃣ Regulation of ginseng adventitious root growth – Plant Physiology and Biochemistry, 2024 (📖 3 citations)
2️⃣ FAR1/FHY3 gene family & MeJA treatment – BMC Plant Biology, 2024 (📖 3 citations)
3️⃣ PgERF120 & ginsenoside biosynthesis – Biomolecules, 2024 (📖 2 citations)
4️⃣ TCP genes & ginsenoside biosynthesis – BMC Plant Biology, 2024 (📖 5 citations)
5️⃣ Small RNA-seq & miRNA expression in ginseng – Plants, 2023 (📖 5 citations)
6️⃣ Trihelix transcription factors & MeJA treatment – BMC Plant Biology, 2023 (📖 5 citations)
7️⃣ PgGT25-04 & ginsenoside biosynthesis – Plants, 2023 (📖 2 citations)
8️⃣ NF-Y transcription factors & salt stress response – BMC Plant Biology, 2022 (📖 13 citations)
9️⃣ WRKY gene family & salt stress response – Horticulturae, 2022 (📖 6 citations)
🔟 Ginsenoside Rb3 synthesis & MeJA treatment – Life, 2021 (📖 5 citations)
1️⃣1️⃣ SPL gene family & network interaction – Plants, 2020 (📖 5 citations)
1️⃣2️⃣ GRAS gene family & GA stress response – Plants, 2020 (📖 18 citations)
1️⃣3️⃣ Spatial & temporal transcriptomic landscapes of ginseng – Scientific Reports, 2015 (📖 64 citations)

📜 Patents:
🔹 PgMYC24 Gene Function & Application in Ginseng – Patent No. ZL 202310794775.X (2024)
🔹 PgJAZ12 Gene Function & Application in Ginseng – Patent No. ZL 202310794490.6 (2024)

Panagiotis Liakos | Medicine and Health Sciences | Best Researcher Award

Posted on 11/11/202411/11/2024 by ScienceFather

Panagiotis Liakos | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Panagiotis Liakos, Faculty of Medicine, University of Thessaly, Greece

Prof. Dr. Panagiotis Liakos is an esteemed biochemist and researcher specializing in cellular biochemistry and hypoxia-related cancer mechanisms. He earned his Maîtrise, Master’s, and Ph.D. in Molecular and Cellular Biology from Joseph Fourier I University, France. His postdoctoral work at Aristotle University in Greece laid the foundation for his academic career, leading him to his current role as Professor and Director of the Department of Basic and Applied Biomedical Sciences at the University of Thessaly. His research focuses on hypoxia-inducible factors (HIFs), particularly HIF-2α, exploring its role in cancer and angiogenesis. 🧬👨‍🔬📚

Publication Profile

google scholar

Education

Prof. Dr. Panagiotis Liakos is a distinguished biochemist with a career spanning from Grenoble to Greece. He completed a Maîtrise in Biochemistry (1994) and a Master’s in Molecular and Cellular Biology (1995) at Joseph Fourier I University, France, followed by a PhD (1999) in Biochemistry and Cellular Endocrine Regulation. His postdoctoral research was conducted at Aristotle University Thessaloniki. In 2003, he became a Lecturer at the University of Thessaly, advancing to Professor in 2022. Currently, he leads the Department of Basic and Applied Biomedical Sciences. His clinical expertise includes years at Larissa University Hospital. 🌍🔬📚👨‍🔬💼

Research Project

Prof. Dr. Panagiotis Liakos has significantly contributed to pioneering health research. Highlights include leading the French Ministry of Health’s 1994 Breast Cancer Prevention program, advancing studies on ACTH receptor expression in adrenal glands (1995-1998), and collaborating on a French-Portuguese program to analyze steroidogenic enzymes in rats and adrenal carcinomas. Furthering adrenal cancer research, he partnered with the Fondation pour la Recherche Médicale (1998-1999). Dr. Liakos explored metalloproteases in skin pathophysiology in a Greek program (2001-2003) and obesity rates in Thessaly (2005-06). His work on signaling pathways under hypoxic stress enriches endocrine research. 🧬🔬

Experience

Prof. Dr. Panagiotis Liakos has been a dedicated educator and coordinator in molecular biology, genetics, and biochemistry since 2001. He taught Biochemistry I & II and Clinical Biochemistry at Democritus University of Thrace, later joining the University of Thessaly to instruct Molecular Biology, Metabolism Regulation, and various biochemistry courses. Since 2004, he has led the Clinical Biochemistry course for medical students and coordinated the Cellular Signaling course in molecular medicine. His teaching repertoire includes postgraduate courses on reproduction genetics, human genetics, and balanced nutrition. Prof. Liakos’s commitment to education spans two decades, fostering expertise in health sciences. 📘🧬👨‍🏫✨

Honors

Prof. Dr. Panagiotis Liakos has been recognized internationally for his research achievements, receiving prestigious scholarships and fellowships from the French Ministry of Research and Fondation pour la Recherche Médicale. These honors underscore his dedication and impactful contributions to his field, highlighting the global relevance of his work. Through these awards, Dr. Liakos has advanced his research, fostering significant progress and collaboration. His achievements not only emphasize his scientific expertise but also reflect his commitment to excellence in research and innovation. 🌍📚🔬

Research Focus

Prof. Dr. Panagiotis Liakos specializes in cellular and molecular biology, particularly focusing on hypoxia and its effects on cellular processes. His research explores how hypoxia-inducible factors (HIFs), especially HIF-1 and HIF-2, regulate gene expression under low-oxygen conditions and influence cancer progression, lipid metabolism, and viral replication. Dr. Liakos’s work also examines the effects of oxidative stress and signaling pathways like PI-3K and MAPK on cellular adaptation to hypoxic stress. His contributions are significant in understanding hypoxia’s role in disease states such as cancer and liver disease, and its broader implications for therapeutic development. 🧬🩺🔬🌬️📊

Publication Top Notes

Hypoxia causes triglyceride accumulation by HIF-1-mediated stimulation of lipin 1 expression

Cobalt induces hypoxia-inducible factor-1α (HIF-1α) in HeLa cells by an iron-independent, but ROS-, PI-3K-and MAPK-dependent mechanism

Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells

The role of hypoxia‐inducible factor‐2 alpha in angiogenesis

Cushing’s syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis

Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells

Tatsuya Nakanowatari | Medicine and Health Sciences | Best Researcher Award

Posted on 27/09/202427/09/2024 by ScienceFather

Tatsuya Nakanowatari | Medicine and Health Sciences | Best Researcher Award

Dr Tatsuya Nakanowatari, Fukushima Medical University, Japan

Based on Dr. Tatsuya Nakanowatari’s impressive academic background and research achievements, he appears to be a strong candidate for the Best Researcher Award. Below is a summary of his accomplishments:

Publication profile

Scopus

Education and Training

Dr. Nakanowatari holds a PhD in Physiotherapy from the University of Newcastle, Australia (2023) and a Master’s degree in Disability Sciences from Tohoku University Graduate School of Medicine (2011). He also has a BS in Physical Therapy from Yamagata Prefectural University of Health Science (2004).

Research and Publications

Loading Asymmetry as a Predictor of Frailty (2024) In a study published in Sensors, Dr. Nakanowatari and colleagues used in-shoe sensors to assess gait asymmetry in community-dwelling older adults. The research identified loading asymmetry as a potential predictor of frailty, a crucial finding for fall prevention and early diagnosis in aging populations.
Detecting Limb Load Asymmetry (2023) In Gait Posture, Dr. Nakanowatari examined limb load asymmetry between fallers and non-fallers among older adults using in-shoe sensors. The study highlighted significant gait differences that can aid in predicting fall risk in elderly individuals, a critical area in physical rehabilitation.
Plantar Force Variation during Treadmill Walking (2024) His preliminary study in Biomedical Human Kinetics explored the effects of walking speed on plantar forces across different foot regions. The research employed force-sensing insoles and provided valuable insights into the biomechanical aspects of gait.
Tensor Fasciae Latae Length and Leg Length Discrepancy (2022) In a study published in the Journal of Back and Musculoskeletal Rehabilitation, Dr. Nakanowatari examined the effect of shoe lifts on the tensor fasciae latae using ultrasonic elastography. The findings contributed to understanding how artificial leg length discrepancies impact musculoskeletal health.
Insular Lesion and Perception of Noxious Stimulation (2022) Published in Internal Medicine, this case study involved a patient with a unilateral insular lesion exhibiting bilaterally reduced pain perception. The research provided deeper insight into the neurological mechanisms behind pain perception and the impact of brain lesions.

Conclusion

Dr. Nakanowatari’s research primarily focuses on biomechanics, frailty, and neuromuscular health in older adults. His innovative use of sensor technology for gait analysis and muscle function assessment positions him as an influential figure in physical therapy research. His work is not only advancing scientific understanding but also making practical contributions to improving patient outcomes, making him a strong contender for the Best Researcher Award.

Publication top notes

In-Shoe Sensor Measures of Loading Asymmetry during Gait as a Predictor of Frailty Development in Community-Dwelling Older Adults

Effects of speed on plantar forces in three-foot regions during treadmill walking: A preliminary study using force sensing insoles

Detecting differences in limb load asymmetry during walking between older adult fallers and non-fallers using in-shoe sensors

The effect of a shoe lift on tensor fasciae latae length during standing with an artificial functional leg length discrepancy: An ultrasonic shear wave elastography study

A Case of Supernumerary Phantom Limb and Suspected Posterior Alien Hand Syndrome after Pontine Hemorrhage

Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Posted on 21/09/202421/09/2024 by ScienceFather

Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Mr Alfonso Luca Pendolino, University College London, United Kingdom

Based on Mr. Alfonso Luca Pendolino’s experience and research, he could be considered a strong candidate for the Best Researcher Award. Here’s why:

Publication profile

Scopus

Education

From October 2021, a part-time PhD student at UCL’s Ear Institute focused on olfactory dysfunction in chronic respiratory diseases. Clinical Fellow at the Royal National Throat, Nose & Ear Hospital, London. Delivered oral presentations at ERS Thessaloniki 2021 on nasal septal perforation repair and the triple-layer technique. Earned a diploma in Otorhinolaryngology from the University of Padova with magna cum laude honors. Actively engaged in various courses, including Balloon Sinuplasty in Guildford and Smell and Taste 11 in Dresden. Member of ENT UK and the British Rhinological Society, with scientific habilitation in Italy. ✨👃📚💼

Experience

From October 2023 to October 2024, the user works as a Senior Clinical Fellow at St George’s University Hospital NHS Foundation Trust in Ear, Nose, and Throat Surgery, focusing on rhinology and anterior skull base procedures. From February 2019 to October 2023, they held a similar role at the Royal National Throat, Nose and Ear Hospital, part of University College London Hospitals. Since October 2019, they have also been pursuing a PhD in the Ear Institute at University College London, focusing on research. Previously, from December 2014 to December 2018, they trained as a resident in Otolaryngology at the University of Padova. 🎓🩺📊

Expertise and Contributions

Mr. Pendolino has extensive clinical and academic experience in Ear, Nose, and Throat (ENT) surgery, particularly in rhinology and anterior skull base procedures. His work spans senior clinical fellowships at prestigious institutions like St. George’s University Hospital and the Royal National Throat, Nose, and Ear Hospital, combined with a PhD research focus on olfactory dysfunction at the University College London (UCL). This academic engagement showcases his commitment to advancing medical science, specifically in rhinology.

Notable Research and Publications

He has contributed significantly to academic research, authoring several impactful papers on topics such as nasal septal perforation repair, cocaine-induced destructive lesions, and smell loss related to COVID-19. His recent publications in high-impact journals such as Diagnostics and Laryngoscope address both clinical outcomes and advanced ENT techniques, demonstrating a broad impact on both scientific understanding and patient care.

Continuous Learning and Development

Throughout his career, Mr. Pendolino has pursued a range of certifications and courses, from endoscopic skull base surgery to rhinoplasty, which highlights his dedication to continual professional development. His involvement in international conferences, including oral communications and workshops, further positions him as a leader in his field.

Research Impact

Although many of his papers have limited citations due to their recent publication, his research has already influenced surgical practices and patient outcomes, especially concerning sinus surgery and chronic respiratory disease management.

conclusion

Mr. Pendolino’s combination of clinical expertise, high-quality research, and ongoing contributions to ENT surgery make him a commendable candidate for the Best Researcher Award.